302 related articles for article (PubMed ID: 23633203)
21. Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG; Gaal J; Corssmit EP; Oudijk L; Korpershoek E; Heimdal K; Bayley JP; Morreau H; van Dooren M; Papaspyrou K; Schreiner T; Hansen T; Andresen PA; Restuccia DF; van Kessel I; van Leenders GJ; Kros JM; Looijenga LH; Hofland LJ; Mann W; van Nederveen FH; Mete O; Asa SL; de Krijger RR; Dinjens WN
Eur J Endocrinol; 2014 Jan; 170(1):1-12. PubMed ID: 24096523
[TBL] [Abstract][Full Text] [Related]
22. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma.
Cascon A; Ruiz-Llorente S; Cebrian A; Telleria D; Rivero JC; Diez JJ; Lopez-Ibarra PJ; Jaunsolo MA; Benitez J; Robledo M
Eur J Hum Genet; 2002 Aug; 10(8):457-61. PubMed ID: 12111639
[TBL] [Abstract][Full Text] [Related]
24. Usefulness of negative and weak-diffuse pattern of SDHB immunostaining in assessment of SDH mutations in paragangliomas and pheochromocytomas.
Castelblanco E; Santacana M; Valls J; de Cubas A; Cascón A; Robledo M; Matias-Guiu X
Endocr Pathol; 2013 Dec; 24(4):199-205. PubMed ID: 24096807
[TBL] [Abstract][Full Text] [Related]
25. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
[TBL] [Abstract][Full Text] [Related]
26. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Branzoli F; Salgues B; Marjańska M; Laloi-Michelin M; Herman P; Le Collen L; Delemer B; Riancho J; Kuhn E; Jublanc C; Burnichon N; Amar L; Favier J; Gimenez-Roqueplo AP; Buffet A; Lussey-Lepoutre C
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36449569
[TBL] [Abstract][Full Text] [Related]
27. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
[TBL] [Abstract][Full Text] [Related]
29. Risk of metastatic pheochromocytoma and paraganglioma in
Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH
J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053
[TBL] [Abstract][Full Text] [Related]
30. Pituitary adenoma associated with pheochromocytoma/paraganglioma: A new form of multiple endocrine neoplasia.
Guerrero Pérez F; Lisbona Gil A; Robledo M; Iglesias P; Villabona Artero C
Endocrinol Nutr; 2016 Nov; 63(9):506-508. PubMed ID: 27639663
[No Abstract] [Full Text] [Related]
31. SDHA is a tumor suppressor gene causing paraganglioma.
Burnichon N; Brière JJ; Libé R; Vescovo L; Rivière J; Tissier F; Jouanno E; Jeunemaitre X; Bénit P; Tzagoloff A; Rustin P; Bertherat J; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2010 Aug; 19(15):3011-20. PubMed ID: 20484225
[TBL] [Abstract][Full Text] [Related]
32. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract][Full Text] [Related]
33. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
34. A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma.
MacFarlane J; Seong KC; Bisambar C; Madhu B; Allinson K; Marker A; Warren A; Park SM; Giger O; Challis BG; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2020 Nov; 93(5):528-538. PubMed ID: 32686200
[TBL] [Abstract][Full Text] [Related]
35. [Rare forms of hereditary endocrine neoplasia: co-existence of pituitary adenoma and pheochromocytoma/paraganglioma].
Mamedova EO; Lisina DV; Belaya ZE
Probl Endokrinol (Mosk); 2023 May; 69(2):24-30. PubMed ID: 37448268
[TBL] [Abstract][Full Text] [Related]
36. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
[TBL] [Abstract][Full Text] [Related]
37. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract][Full Text] [Related]
38. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
39. In Vivo Detection of Succinate by Magnetic Resonance Spectroscopy as a Hallmark of SDHx Mutations in Paraganglioma.
Lussey-Lepoutre C; Bellucci A; Morin A; Buffet A; Amar L; Janin M; Ottolenghi C; Zinzindohoué F; Autret G; Burnichon N; Robidel E; Banting B; Fontaine S; Cuenod CA; Benit P; Rustin P; Halimi P; Fournier L; Gimenez-Roqueplo AP; Favier J; Tavitian B
Clin Cancer Res; 2016 Mar; 22(5):1120-9. PubMed ID: 26490314
[TBL] [Abstract][Full Text] [Related]
40. Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma.
Kim ES; Kim SY; Mo EY; Jang DK; Moon SD; Han JH
Head Neck; 2014 Dec; 36(12):E131-5. PubMed ID: 24599702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
